Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
US6107331A · kind A · utility
26Cited by
32References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 1997 |
| Grant date | Aug 22, 2000 |
| Priority date | — |
| Expiry date | Feb 21, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel methods of inhibiting pathological conditions related to organ systems which respond to estrogen agonists comprising administering to a mammal in need of such treatment an effective amount of a compound of formula I ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.